Eddie Joe Sullivan - 15 Jul 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
PRESIDENT, Director
Signature
/s/ Eddie Joe Sullivan
Issuer symbol
SABS
Transactions as of
15 Jul 2024
Net transactions value
$0
Form type
4
Filing time
17 Jul 2024, 16:30:11 UTC
Previous filing
23 Feb 2024
Next filing
28 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +46,528 $0.000000 46,528 15 Jul 2024 Common Stock 46,528 $5.40 Direct F1, F3
transaction SABS Stock Option (right to buy) Award $0 +4,447 $0.000000 4,447 15 Jul 2024 Common Stock 4,447 $2.90 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option are fully vested.
F2 Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028.
F3 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.